Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 2456
TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20754(8-(1,3-benzothiazol-2-ylsulfanyl)-9-butyl-9H-purin...)
Affinity DataEC50:  5.00E+3nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20786(3-[6-amino-8-({7-chloropyrido[3,4-d][1,3]thiazol-2...)
Affinity DataEC50:  170nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20756(9-butyl-8-[(4-chloro-1,3-benzothiazol-2-yl)sulfany...)
Affinity DataEC50:  1.50E+4nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20757(9-butyl-8-[(6-chloro-1,3-benzothiazol-2-yl)sulfany...)
Affinity DataEC50:  7.00E+3nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20758(9-butyl-8-[(7-chloro-1,3-benzothiazol-2-yl)sulfany...)
Affinity DataEC50:  180nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20759(8-[(7-bromo-1,3-benzothiazol-2-yl)sulfanyl]-9-buty...)
Affinity DataEC50:  330nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20760(9-butyl-8-[(7-fluoro-1,3-benzothiazol-2-yl)sulfany...)
Affinity DataEC50:  200nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20761(9-butyl-8-[(7-methyl-1,3-benzothiazol-2-yl)sulfany...)
Affinity DataEC50:  300nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20762(9-butyl-8-[(6,7-dichloro-1,3-benzothiazol-2-yl)sul...)
Affinity DataEC50:  2.50E+4nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20763(9-butyl-8-[(7-methoxy-1,3-benzothiazol-2-yl)sulfan...)
Affinity DataEC50:  190nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20764(9-butyl-8-[(7-ethoxy-1,3-benzothiazol-2-yl)sulfany...)
Affinity DataEC50:  1.00E+5nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20765(8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9-eth...)
Affinity DataEC50:  200nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20766(8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9-pro...)
Affinity DataEC50:  250nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20767(8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9-pen...)
Affinity DataEC50:  700nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20768(2-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulf...)
Affinity DataEC50:  150nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20769(3-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulf...)
Affinity DataEC50:  90nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20770(4-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulf...)
Affinity DataEC50:  130nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20771(Benzothiazole analogue, 24 | CHEMBL377371 | diethy...)
Affinity DataEC50:  30nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20772(5-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulf...)
Affinity DataEC50:  110nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20773(2-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulf...)
Affinity DataEC50:  300nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20774(3-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulf...)
Affinity DataEC50:  150nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20775(4-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulf...)
Affinity DataEC50:  150nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20776(8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9-[2-...)
Affinity DataEC50:  250nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20777(9-[2-(tert-butylamino)ethyl]-8-[(7-chloro-1,3-benz...)
Affinity DataEC50:  140nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20778(8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9-{2-...)
Affinity DataEC50:  35nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20779(8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9-[2-...)
Affinity DataEC50:  110nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20780(8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9-[3-...)
Affinity DataEC50:  170nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20781(9-[3-(tert-butylamino)propyl]-8-[(7-chloro-1,3-ben...)
Affinity DataEC50:  150nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20782(8-({7-bromopyrido[3,4-d][1,3]thiazol-2-yl}sulfanyl...)
Affinity DataEC50:  400nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20783(CHEMBL212133 | Pyridothiazole analogue, 27 | dieth...)
Affinity DataEC50:  28nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20784(9-butyl-8-({7-chloropyrido[3,4-d][1,3]thiazol-2-yl...)
Affinity DataEC50:  280nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20785(CHEMBL212850 | Pyridothiazole analogue, 29 | dieth...)
Affinity DataEC50:  30nMAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHeat shock protein HSP 90-beta(Human)
Conforma Therapeutics

LigandPNGBDBM20755(9-butyl-8-[(5-chloro-1,3-benzothiazol-2-yl)sulfany...)
Affinity DataEC50:  2.00E+4nMpH: 7.2 T: 37°CAssay Description:EC50 was defined as the concentration of the compound at which there was 50% degradation of the Her-2/neu protein in MCF7 breast carcinoma cells. Sam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed